Sort   by:  
 Page size 
UnknownLongitudinal Analysis of the Utility of Liver Biochemistry as Prognostic Markers in Hospitalized Patients With Corona Virus Disease 2019.
Not available
S-EPMC8239606 | biostudies-literature
UnknownHLA ligandome analysis of primary chronic lymphocytic leukemia (CLL) cells under lenalidomide treatment confirms the suitability of lenalidomide for combination with T-cell-based immunotherapy.
Not available
S-EPMC5889201 | biostudies-literature
UnknownMidostaurin plus intensive chemotherapy for younger and older patients with AML and FLT3 internal tandem duplications.
Not available
S-EPMC9631686 | biostudies-literature
UnknownHLA class I-restricted MYD88 L265P-derived peptides as specific targets for lymphoma immunotherapy.
Not available
S-EPMC5384368 | biostudies-literature
ProteomicsThe HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapy
Anti-leukemia immunity plays an important role for disease control and maintenance of tyrosine kinase inhibitor (TKI)-free remission in chronic myeloid leukemia (CML). Antigen-specific immunotherapy holds promise to strengthen immune control in CML, but requires the identification of CML-associated ...
ORGANISM(S): Homo sapiens (Human) 
2018-12-11 | PXD010450 | Pride
Mass spectrometry Chronic myeloid leukemia Immunopeptidome 
UnknownTOF<sub>IMS</sub> mass spectrometry-based immunopeptidomics refines tumor antigen identification.
Not available
S-EPMC10656517 | biostudies-literature
ProteomicsImmune surveillance of acute myeloid leukemia is mediated by HLA-presented antigens on leukemia progenitor cells
Persistent therapy-resistant leukemic progenitor cells (LPC) are a main cause of disease relapse and recurrence in acute myeloid leukemia (AML). Specific LPC-targeting therapies may thus improve treatment outcome of AML patients. We demonstrate that LPCs present human leukocyte antigen (HLA)-restric...
ORGANISM(S): Homo sapiens (Human) 
2023-08-23 | PXD038691 | Pride
Mass spectrometry Acute myeloid leukemia Immunotherapy Immunopeptidomics Leukemic progenitor cells Hla peptides 
UnknownPathogenic fungi regulate immunity by inducing neutrophilic myeloid-derived suppressor cells.
Not available
S-EPMC4400268 | biostudies-literature
UnknownAbsence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion.
Not available
S-EPMC6934414 | biostudies-literature
UnknownImmune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor Cells.
Not available
S-EPMC10618727 | biostudies-literature
Sort   by:  
 Page size